RhizeBio
PrivateLast Round
Accelerator
Jan 17, 2024
Est. Valuation
$2M
Total Funding Raised
$200,000
Company Overview
RhizeBio operates in Healthcare & Life Sciences and is based in Mount Holly, North Carolina. Its latest recorded funding round was an Accelerator round in January 2024.
RhizeBio is an ag-tech company that provides soil testing services using metagenomic sequencing and AI to track biodiversity and soil health for improved farm productivity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RhizeBio Comparables
Compare RhizeBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biome Makers | 85% | |
| Miraterra | 85% | |
| Elaniti | 84% |
For institutional investors. Book with your work email.
RhizeBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 17, 2024 | ||||
| Accelerator | Sep 6, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RhizeBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Grit Road Partners | Accelerator |
| AgLaunch Accelerator | Accelerator |
| Praxis | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors increased 43% MoM.
- Oct 16, 2025
Grew 38% QoQ from 8 to 11 employees.
For institutional investors. Book with your work email.
RhizeBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RhizeBio's valuation, stock price, and market status.
Is RhizeBio a public or private company?
RhizeBio is a private company.
What is the current stock price of RhizeBio?
RhizeBio is a private company, so its shares have no public market price. Caplight tracks RhizeBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RhizeBio worth (valuation)?
RhizeBio's valuation is estimated at $2.0M based on funding round data.
Can I buy RhizeBio stock?
RhizeBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RhizeBio's last funding round?
RhizeBio's most recent funding round was Accelerator on January 17, 2024.
Who are the main investors in RhizeBio?
Key investors in RhizeBio include Praxis.
Will RhizeBio IPO soon?
No public IPO plans have been announced for RhizeBio.
How can I track RhizeBio secondary market activity?
Caplight tracks bids, offers, and trades in RhizeBio's shares on secondary markets.